PATENT CLAIM ANALYSIS

Application Number: 15894544
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "502000"]

Abstract:
The present invention provides methods of treating soft tissue calcification in a subject, comprising a step of administering to said subject an effective amount of ferric organic compound, such as ferric citrate. The claimed methods may prevent, reverse, delay or stabilize soft tissue calcification in a subject having chronic kidney disease. Affected soft tissue calcification includes soft tissue calcification in the joint, skin, eye, in cardiovascular system such as heart valve, myocardium, coronary arteries and arteriole, or in internal organs such as kidney and lung.

Claim (Index 75):
A method of reversing soft tissue calcification in a subject, comprising administering to said subject an effective amount of ferric citrate, wherein soft tissue calcification is reversed.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.68966
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15694876', '12162558', '12064058', '13661558', '13289048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.767812155804838
- 35 USC 102 Novelty (BERT): 0.5533615422347009
- Combined Prediction Score: 0.7463670944478242
- Mean Citation Score: 346.132312
- Max Citation Score: 425.66412
- Similarity Product: 356.3133239408184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test